Status:
COMPLETED
Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation
Lead Sponsor:
Mayo Clinic
Conditions:
Liver Transplant Surgery
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research is to estimate the frequency of postoperative lasting muscle weakness in patients receiving Sugammadex after undergoing liver transplant surgery by using electromyographic...
Eligibility Criteria
Inclusion
- Patients willing to participate and provide an informed consent.
- Patients undergoing primary liver transplantation.
Exclusion
- Patients with unilateral disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
- Patients with systemic neuromuscular diseases such as myasthenia gravis.
- Patients with a known history of cerebrovascular accident (CVA).
- Patients undergoing repeat liver transplantation or concomitant pancreas/kidney transplantation at the time of liver transplantation.
- Patients admitted to the intensive care unit prior to liver transplantation.
Key Trial Info
Start Date :
October 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 21 2025
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT05216991
Start Date
October 20 2022
End Date
January 21 2025
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Florida
Jacksonville, Florida, United States, 32224